A
ISSUER//CIK 0001836056
Ambrx Biopharma Cayman, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Cayman Islands
Recent Filings
- SC 13G/A132.4 KBAmbrx Biopharma Cayman, Inc.Feb 9, 5:08 PM ET·0001193125-24-030277
- 8-K225.2 KBAmbrx Biopharma Inc.Oct 10, 4:49 PM ET·0001193125-23-253527
- SC 13G53.6 KBAmbrx Biopharma Inc.Oct 10, 11:35 AM ET·0001140361-23-047537
- SC 13G77.8 KBAmbrx Biopharma Inc.Sep 25, 5:24 PM ET·0001104659-23-103570
- 8-K233.8 KBAmbrx Biopharma Inc.Sep 22, 5:36 PM ET·0000950170-23-049468
- 8-K235.4 KBAmbrx Biopharma Inc.Sep 6, 4:05 PM ET·0000950170-23-046718
- 8-K14.1 MBAmbrx Biopharma Inc.Apr 10, 6:43 AM ET·0001193125-23-095792
- SC 13G/A113.6 KBAmbrx Biopharma Inc.Mar 13, 4:00 PM ET·0000929638-23-000830
- 8-K223.5 KBAmbrx Biopharma Inc.Mar 13, 8:00 AM ET·0001193125-23-068506
- 8-K215.3 KBAmbrx Biopharma Inc.Mar 6, 9:00 AM ET·0001193125-23-060814
Insiders
10Tickers
No tickers on record
Addresses
business
10975 NORTH TORREY PINES ROAD
LA JOLLA, CA, 92037
mailing
10975 NORTH TORREY PINES ROAD
LA JOLLA, CA, 92037
Former Names
- Ambrx Biopharma Inc.2023-10-10